| DURECT-CORPORATION |
DURECT-CORPORATION |
85%
|
e identifiable intangible assets is determined primarily using the “income approach,” which requires a forecast of the expected future cash flows (including revenue growth rates, cost of goods sold, … |
| PAYORS |
PAYORS |
85%
|
We also concentrate on managing our relationships with our payors and wholesalers |
| SHIBO-GROUP |
SHIBO-GROUP |
85%
|
ii) covered by third-party payors or (iv) profitable for distribution, is highly uncertain. The commitment periods under these agreements vary and include customary termination provisions. Expenses a… |
| WHOLESALERS |
WHOLESALERS |
85%
|
We also concentrate on managing our relationships with our payors and wholesalers |
| WUHAN-SHIBO-ZHENMEI-TECHNOLOGY-CO-LTD |
WUHAN-SHIBO-ZHENMEI-TECHNOLOGY-CO-LTD |
85%
|
ii) covered by third-party payors or (iv) profitable for distribution, is highly uncertain. The commitment periods under these agreements vary and include customary termination provisions. Expenses a… |
| BLCO |
Bausch + Lomb Corporation |
72%
|
difference between the payment due and the calculated interest at the effective interest rate of the underlying carry amount of the associated note. During the three months ended March 31, 2026 and 2… |
| BLCO |
Bausch + Lomb Corporation |
72%
|
Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC graph: Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC graph: Reciprocal relationship from BLCO gra… |
| IRIX |
IRIDEX Corporation |
72%
|
Reciprocal relationship from IRIX graph: Reciprocal relationship from BHC graph: Reciprocal relationship from IRIX graph: Reciprocal relationship from BHC graph: Reciprocal relationship from IRIX gra… |
| KR |
The Kroger Co. |
72%
|
Reciprocal relationship from KR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from KR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from KR graph: Re… |
| LNSR |
LENSAR, Inc. |
72%
|
Reciprocal relationship from LNSR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from LNSR graph: zation efforts will provide us with significant opportunity for future growth… |
| MNPR |
Monopar Therapeutics Inc. |
72%
|
Reciprocal relationship from MNPR graph: ing on new radiopharmaceutical compounds and linkers. 11 Table of Contents Manufacturing ALXN1840 We do not currently own or operate manufacturing facilities … |
| RDHL |
RedHill Biopharma Ltd. |
72%
|
Reciprocal relationship from RDHL graph: (Prevacid ® ) and branded and generic, prescription and OTC esomeprazole magnesium (Nexium ® ). Prescription dexlansoprazole (Dexilant ®, marketed by Takeda P… |
| SLGL |
Sol-Gel Technologies Ltd. |
72%
|
Reciprocal relationship from SLGL graph: Reciprocal relationship from BHC graph: Reciprocal relationship from SLGL graph: Reciprocal relationship from BHC graph: Reciprocal relationship from SLGL gra… |
| VKTX |
Viking Therapeutics, Inc. |
72%
|
Reciprocal relationship from VKTX graph: y a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP regulations. In addition, our clinica… |
| XENE |
Xenon Pharmaceuticals Inc. |
72%
|
Reciprocal relationship from XENE graph: Reciprocal relationship from BHC graph: Reciprocal relationship from XENE graph: Reciprocal relationship from BHC graph: Reciprocal relationship from XENE gra… |
| B-C-LTD |
B-C-LTD |
62%
|
difference between the payment due and the calculated interest at the effective interest rate of the underlying carry amount of the associated note. During the three months ended March 31, 2026 and 2… |
| OCEANSIDE-PHARMACEUTICALS-INC-BAUSCH-HEALTH-US-L |
OCEANSIDE-PHARMACEUTICALS-INC-BAUSCH-HEALTH-US-L |
62%
|
ejudice. Antitrust Litigation Generic Pricing Antitrust Litigation The Company and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health US, LLC (formerly Valeant Pharmaceuticals North Ame… |
| VALEANT-PHARMACEUTICALS-NORTH-AMERICA-LLC |
VALEANT-PHARMACEUTICALS-NORTH-AMERICA-LLC |
62%
|
ejudice. Antitrust Litigation Generic Pricing Antitrust Litigation The Company and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health US, LLC (formerly Valeant Pharmaceuticals North Ame… |